查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1797676

胶原蛋白及玻尿酸关节内注射的全球市场:产品类型·用途·通路·各地区 (～2035年)

Global Collagen and Hyaluronic Acid Intra-Articular Injections Market by Product Type, by Application, by Distribution Channel, and by Region Forecast till 2035
出版日期: | 出版商: Market Research Future | 英文 184 Pages | 订单完成后即时交付

价格

预计2035年，全球胶原蛋白和透明质酸关节内注射市场规模将达到63.248亿美元，预测期内复合年增长率为6.15%。

透明质酸和胶原蛋白直接注射到关节中用于治疗关节疾病。透明质酸被认为是理想的润滑剂和减震剂，而胶原蛋白是由软骨最基本的组成部分形成的，有助于软骨结构和再生。透过减轻僵硬和疼痛，患者可以恢復失去的功能和活动能力，最终朝着避免手术迈出重要一步。

随着製造商寻求满足骨关节炎、类风湿性关节炎和运动伤害高发病率的需求，胶原蛋白和透明质酸正成为越来越受欢迎的解决方案。由于人口老化以及肥胖和缺乏运动等风险因素的增加，越来越多的患者选择非手术治疗。这些注射在改善关节功能和推迟昂贵的手术方面发挥关键作用，有助于全球市场稳定成长。

区域分析

北美占全球市场收入的大部分，这得益于患者教育水平的提高和关节内注射药物的早期应用。美国在北美胶原蛋白和透明质酸关节内注射市场中处于领先地位，市场规模达到12.1126亿美元，其次是加拿大，市场规模为1.7035亿美元，显示该地区市场需求强劲。由于全面的保险覆盖和一致的临床疗效，这些治疗在美国市场具有很高的可及性。

在欧洲，由于人口预期寿命的提高和对先进治疗的需求，市场规模持续扩大。德国以1.3061亿美元领先欧洲市场，其次是英国（9,489万美元）和法国（8,334万美元）。凭藉广泛的研究和完善的医疗保健网络，德国和法国占了大部分市场占有率。

亚太地区潜力巨大，人口众多的国家需求激增。中国以1.2742亿美元的市场规模位居亚太地区首位，其次是印度（8396万美元），这两个国家都对亚太地区的成长起到了推动作用。日本快速发展的科技生态系统有力地支持了创新，而中国庞大的患者群体则推动了市场规模的成长。

本报告探讨了全球胶原蛋白和透明质酸关节内注射市场，包括市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、按细分市场、地区和主要国家/地区进行的细分、竞争格局以及主要公司的概况。

目录

第1章 摘要整理

第2章 市场简介

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 骨关节炎和关节疾病盛行率上升
    • 老化人口增加
  • 阻碍因素
    • 治疗费用高昂
    • 监理课题
  • 机遇
    • 微创治疗需求不断成长

第5章 市场要素分析

  • 价值链分析
  • 波特的五力分析

第6章 全球胶原蛋白及玻尿酸关节内注射剂市场:各产品类型

  • 概要
  • 玻尿酸注射
  • 胶原蛋白注射
  • 玻尿酸和胶原蛋白的组合

第7章 全球胶原蛋白及玻尿酸关节内注射剂市场:各用途

  • 概要
  • 变形性膝关节症
  • 关节痛
  • 兽医学用途
  • 术后復苏
  • 其他

第8章 全球胶原蛋白及玻尿酸关节内注射剂市场:各流通管道

  • 概要
  • 医院药局
  • 零售药局
  • 线上药局

第9章 全球胶原蛋白及玻尿酸关节内注射剂市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 俄罗斯
    • 西班牙
    • 义大利
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 马来西亚
    • 泰国
    • 印尼
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中东·非洲
    • GCC各国
    • 南非
    • 其他

第10章 竞争情形

  • 市场占有率分析
  • 竞争仪表板
  • 上市公司的股票:摘要
  • 比较分析:主要企业的财务
  • 主要的展开·成长策略

第11章 企业简介

  • SEIKAGAKU CORPORATION
  • BIOVENTUS, INC.
  • ANIKA THERAPEUTICS, INC
  • ZIMMER BIOMET
  • SANOFI
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • FERRING B.V.
  • DR. REDDY'S LABORATORIES LTD.
  • FIDIA FARMACEUTICI S.P.A
  • SEMICAL BIOSURGERY
  • AVANOS MEDICAL, INC.
  • MAXIGEN BIOTECH INC. (MBI)

第12章 资料的引用

Product Code: MRFR/HC/57883-CR

Global Collagen and Hyaluronic Acid Intra-Articular Injections Market by Product Type [Hyaluronic Acid Injection (Single Injection, Multiple Injection), Collagen Injection, Combination of Hyaluronic Acid and Collagen], by Application (Knee Osteoarthritis, Joint Pains, Veterinary Applications, Post-Operative Recovery, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) Forecast till 2035

Industry Overview

The global collagen and hyaluronic acid intra-articular injections market is projected to expand at a 6.15% CAGR, reaching an estimated value of USD 6,324.80 million by 2035. Hyaluronic acid and collagen are injected directly into joints to treat joint disorders. While hyaluronic acid is expected to be the perfect lubricant and shock absorber, collagen, formed of the most basic unit of cartilage, supports the cartilage structure and regeneration. To reduce the stiffness and pain, the patients get back their lost functions and mobility, and this becomes a great step towards the final idea of surgery discontinuance.

Manufacturers are seeking to supply the demand that comes from the high rate of Osteoarthritis, Rheumatoid Arthritis, and sports injuries affecting the joint, and collagen and hyaluronic acid are becoming more and more popular as the solution. Due to the aging of the population and proliferating risk factors like obesity and inactivity, patients tend to decide in favor of non-surgical therapies. These injections have a major role in enhancing the function of the joints and in postponing expensive surgeries, which is the reason for their steady market growth all over the world.

Key Company Development

Ono Pharmaceutical and Seikagaku Corporation have succeeded in reaching a new summit in May 2021 by releasing in Japan JOYCLU 30mg Intra-articular Injection (generic: diclofenac etalhyaluronate sodium), which is a new product. By using their own technology for the binding of hyaluronic acid and diclofenol, Seikagaku has produced a unique drug that not only provides better lubrication but also fights inflammation. Consequently, JOYCLU improves the performance of the joint and resolves the problem of treatment of osteoarthritis, which is an advanced disease in Japan due to the country's aging society issue. In the wake of this event, Seikagaku has decided to introduce the new product line, starting with HyLink, in August 2021. It was conceived as the most recent single-injection viscosupplement for knee osteoarthritis with the aim of simplifying treatment by cutting down the number of injections while delivering sustained relief. In this way, the company affirms not only the needs of the patients but also its commitment to the effectiveness of clinical practice and innovation in musculoskeletal care.

Key Players

Major players in the global collagen and hyaluronic acid intra-articular injection market are Seikagaku Corporation, Bioventus, Inc., Anika Therapeutics, Inc., Zimmer Biomet, Sanofi, Fidia Farmaceutici S.p.A., Teva Pharmaceutical Industries Ltd., Ferring B.V., Dr. Reddy's Laboratories Ltd., Semical Biosurgery, Avanos Medical, Inc., and Maxigen Biotech Inc. (MBI).

Report Attribute Details

Market Size 2024 USD 3,046.46 Million

Market Size 2035 USD 6,324.80 Million

CAGR (2025-2035) 6.15%

Base Year 2024

Market Forecast Period 2025-2035

Historical Data 2019-2024

Market Segmentation Insights

By Product Type: Hyaluronic acid Injection - 6.34%, Collagen Injection - 5.45%.

By Application: Knee Osteoarthritis - 6.52%, Joint Pains - 5.74%.

By Distribution Channel: Hospital Pharmacies - 6.37%, Retail Pharmacies - 5.36%.

Regional Analysis

North America captures most of the global earnings mainly due to the high level of patient education and the early introduction of intra-articular drugs. The U.S. dominates North America's collagen and hyaluronic acid intra-articular injections market at USD 1,211.26 million, with Canada ranking second at USD 170.35 million, highlighting the region's strong demand. Supported by substantial insurance coverage and consistent clinical improvement results, the U.S. market has great accessibility to these treatments.

In Europe, the market expansion continues to be supported by the longer life expectancy of the population and their demand for sophisticated therapies. Germany leads Europe's market at USD 130.61 million, with the UK (USD 94.89 million) and France (USD 83.34 million) following as other key contributors. Germany and France are the two countries that account for the largest part of the market due to the extensive research that has been carried out and the well-established medical networks.

The Asia-Pacific region is full of potential, and thus, the demand is booming in the heavily populated countries. China holds the largest share in Asia-Pacific with USD 127.42 million, whereas India follows with USD 83.96 million, together shaping regional growth.Japan's high-speed technological ecosystem is very supportive of innovation, and China's vast patient pool drives volume growth.

Latin America's market outlook is positive but uneven, with Brazil spearheading adoption due to private healthcare investments. Market expansion is slower in smaller economies due to limited awareness and constrained spending capacity.

The Middle East & Africa market is gradually strengthening with rising demand for orthopedic care. Gulf countries, supported by government-funded health programs, are early adopters of advanced injections. African nations face structural barriers, with access concentrated in urban areas.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW
  • 1.2 MARKET ATTRACTIVENESS ANALYSIS
  • 1.3 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE
  • 1.4 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION
  • 1.5 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL
  • 1.6 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION

2. MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3. RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4. MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 RISING PREVALENCE OF OSTEOARTHRITIS AND JOINT DISORDERS
    • 4.2.2 GROWING AGING POPULATION
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST OF TREATMENT
    • 4.3.2 REGULATORY CHALLENGES
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING DEMAND FOR MINIMALLY INVASIVE TREATMENTS

5. MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY

6 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2 HYALURONIC ACID INJECTION
  • 6.3 COLLAGEN INJECTION
  • 6.4 COMBINATION OF HYALURONIC ACID AND COLLAGEN

7. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 KNEE OSTEOARTHRITIS
  • 7.3 JOINT PAIN
  • 7.4 VETERINARY APPLICATIONS
  • 7.5 POST-OPERATIVE RECOVERY
  • 7.6 OTHERS

8. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL

  • 8.1 OVERVIEW
  • 8.2 HOSPITAL PHARMACIES
  • 8.3 RETAIL PHARMACIES
  • 8.4 ONLINE PHARMACIES

9. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 RUSSIA
    • 9.3.5 SPAIN
    • 9.3.6 ITALY
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 SOUTH KOREA
    • 9.4.5 MALAYSIA
    • 9.4.6 THAILAND
    • 9.4.7 INDONESIA
    • 9.4.8 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 BRAZIL
    • 9.5.2 MEXICO
    • 9.5.3 ARGENTINA
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 GCC COUNTRIES
    • 9.6.2 SOUTH AFRICA
    • 9.6.3 REST OF MEA

10. COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2024
  • 10.3 COMPETITOR DASHBOARD
  • 10.4 PUBLIC PLAYERS STOCK SUMMARY
  • 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
  • 10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.1.1 PRODUCT LAUNCH/APPROVAL

11. COMPANY PROFILES

  • 11.1 SEIKAGAKU CORPORATION
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 BIOVENTUS, INC.
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 ANIKA THERAPEUTICS, INC
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 ZIMMER BIOMET
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCT OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 SANOFI
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 KEY STRATEGIES
  • 11.6 TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 FERRING B.V.
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 DR. REDDY'S LABORATORIES LTD.
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCT OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 KEY STRATEGIES
  • 11.9 FIDIA FARMACEUTICI S.P.A
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 SEMICAL BIOSURGERY
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES
  • 11.11 AVANOS MEDICAL, INC.
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 FINANCIAL OVERVIEW
    • 11.11.3 PRODUCTS OFFERED
    • 11.11.4 KEY DEVELOPMENTS
    • 11.11.5 KEY STRATEGIES
  • 11.12 MAXIGEN BIOTECH INC. (MBI)
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 FINANCIAL OVERVIEW
    • 11.12.3 PRODUCTS OFFERED
    • 11.12.4 KEY DEVELOPMENTS
    • 11.12.5 SWOT ANALYSIS
    • 11.12.6 KEY STRATEGIES

12. DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 3 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 4 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 5 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR COLLAGEN INJECTION, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 6 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR COMBINATION OF HYALURONIC ACID AND COLLAGEN, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 7 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 8 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR KNEE OSTEOARTHRITIS, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 9 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR JOINT PAIN, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 10 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR VETERINARY APPLICATIONS, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 11 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR POST-OPERATIVE RECOVERY, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 12 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR OTHERS, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 13 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 14 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 15 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 16 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 17 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 18 NORTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 19 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 20 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 21 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 22 NORTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 23 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 24 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 25 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 26 US: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 27 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 28 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 29 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 30 CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 31 EUROPE COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 32 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 33 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 34 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 35 EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 36 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 37 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 38 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 39 GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 40 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 41 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 42 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 43 UK: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 44 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 45 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 46 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 47 FRANCE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 48 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 49 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 50 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 51 RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 52 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 53 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 54 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 55 SPAIN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 56 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 57 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 58 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 59 ITALY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 60 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 61 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 62 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 63 REST OF EUROPE: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 64 ASIA PACIFIC COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 69 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 70 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 71 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 72 CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 73 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 74 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 75 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 76 INDIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 77 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 78 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 79 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 80 JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 81 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 82 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 83 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 84 SOUTH KOREA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 85 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 86 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 87 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 88 MALAYSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 89 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 90 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 91 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 92 THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 93 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 94 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 95 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 96 INDONESIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 97 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 98 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 99 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 100 REST OF ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 101 SOUTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 102 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 103 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 104 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 105 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 106 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 107 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 108 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 109 BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 110 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 111 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 112 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 113 MEXICO: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 114 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 115 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 116 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 117 ARGENTINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 118 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 119 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 120 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 121 REST OF LATIN AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 122 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 123 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 124 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 125 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 126 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 127 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 128 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 129 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 130 GCC COUNTRIES: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 131 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 132 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 133 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 134 SOUTH AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 135 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  • TABLE 136 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC ACID INJECTION, BY TYPE, 2019-2035 (USD MILLION)
  • TABLE 137 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 138 REST OF MEA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  • TABLE 139 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 140 PRODUCT LAUNCH/APPROVAL
  • TABLE 141 SEIKAGAKU CORPORATION.: PRODUCTS OFFERED
  • TABLE 142 SEIKAGAKU CORPORATION: KEY DEVELOPMENTS
  • TABLE 143 BIOVENTUS, INC.: PRODUCTS OFFERED
  • TABLE 144 BIOVENTUS, INC.: KEY DEVELOPMENTS
  • TABLE 145 ANIKA THERAPEUTICS, INC: PRODUCTS OFFERED
  • TABLE 146 ZIMMER BIOMET: PRODUCTS OFFERED
  • TABLE 147 SANOFI: PRODUCTS OFFERED
  • TABLE 148 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED
  • TABLE 149 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY DEVELOPMENTS
  • TABLE 150 FERRING B.V.: PRODUCT OFFERED
  • TABLE 151 DR. REDDY'S LABORATORIES LTD.: PRODUCTS OFFERED
  • TABLE 152 FIDIA FARMACEUTICI S.P.A.: PRODUCT OFFERED
  • TABLE 153 SEMICAL BIOSURGERY: PRODUCT OFFERED
  • TABLE 154 AVANOS MEDICAL, INC.: PRODUCT OFFERED
  • TABLE 155 MAXIGEN BIOTECH INC.(MBI): PRODUCT OFFERED
  • TABLE 156 MAXIGEN BIOTECH INC.(MBI): KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET,
  • FIGURE 2 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET ANALYSIS, BY PRODUCT TYPE,
  • FIGURE 3 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS ANALYSIS, BY APPLICATION,
  • FIGURE 4 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS ANALYSIS, BY DISTRIBUTION CHANNEL,
  • FIGURE 5 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET ANALYSIS, BY REGION,
  • FIGURE 1 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2035)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET
  • FIGURE 7 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2024 (USD MILLION)
  • FIGURE 8 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION)
  • FIGURE 9 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE (%), BY PRODUCT TYPE,
  • FIGURE 10 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2024 (USD MILLION)
  • FIGURE 11 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION)
  • FIGURE 12 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE (%), BY APPLICATION,
  • FIGURE 13 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2024 (USD MILLION)
  • FIGURE 14 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2024 & 2035 (USD MILLION)
  • FIGURE 15 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE (%), BY DISTRIBUTION CHANNEL,
  • FIGURE 16 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY REGION, 2024 & 2035 (USD MILLION)
  • FIGURE 17 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY REGION, 2024 (%)
  • FIGURE 18 NORTH AMERICA MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2035 (USD MILLION)
  • FIGURE 19 NORTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 20 NORTH AMERICA COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 21 EUROPE MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2035 (USD MILLION)
  • FIGURE 22 EUROPE COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 23 EUROPE COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 24 ASIA-PACIFIC MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 25 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 26 ASIA PACIFIC: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 27 LATIN AMERICA MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 28 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 29 SOUTH AMERICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 30 MIDDLE EAST AND AFRICA MARKET ANALYSIS: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 31 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 32 MIDDLE EAST AND AFRICA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 33 GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 34 COMPETITOR DASHBOARD: GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET
  • FIGURE 35 SEIKAGAKU CORPORATION.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 SEIKAGAKU CORPORATION.: SWOT ANALYSIS
  • FIGURE 37 BIOVENTUS, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 BIOVENTUS, INC: SWOT ANALYSIS
  • FIGURE 39 ANIKA THERAPEUTICS, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 ANIKA THERAPEUTICS INC.: SWOT ANALYSIS
  • FIGURE 41 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 42 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 44 FERRING B.V.: SWOT ANALYSIS
  • FIGURE 45 DR. REDDY'S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 46 AVANOS MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 47 MAXIGEN BIOTECH INC.(MBI): FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 MAXIGEN BIOTECH INC.(MBI): SWOT ANALYSIS